Compare AbCellera Biologics Inc (ABCL) vs American Express Co (AXP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs American Express Co — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while American Express Co trades at $340.05 (market cap $230.15B). The key difference: American Express Co is far larger — about 77× AbCellera Biologics Inc's market cap, and American Express Co pays a 1.11% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AXP | |
|---|---|---|
Market Cap | $2.99B | $230.15B |
Sector | Health | Financials |
52-Week High | $9.76 | $384.82 |
52-Week Low | $2.78 | $292.27 |
Enterprise Value | $2.58B | — |
Dividend Yield | — | 1.11% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About American Express Co
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →
